| (P1726) |
Two Years Clinical Outcomes of Diabetic Patients Treated With a New Generation Drug-Eluting Stent |
|
M. Wiemer, Z. Dimitriadis, M. Vlachojannis, D. Vogler, D. Horstkotte, G. B. Danzi (Bad Oeynhausen; Milano, IT) |
| (P1727) |
Paclitaxel-Coated Balloons After Bare Metal Stent Placement in Successfully Recanalized Chronic Total Coronary Occlusions |
|
J. Wöhrle, S. Markovic, W. Rottbauer, G. S. Werner (Ulm, Darmstadt) |
| (P1728) |
PERfECT STENT: A ProspEctive, Randomized Trial Evaluating a Paclitaxel-Eluting Balloon plus Endothelial Progenitor Cell CapTuring Stents for De Novo Coronary Artery Disease - 24 months results |
|
J. Wöhrle, R. Birkemeyer, S. Markovic, B. Blüm, T. Miljak, J. Spieß, W. Rottbauer, H. Rittger (Ulm, Villingen-Schwenningen, Coburg, Erlangen) |
| (P1729) |
Everolimus-eluting stents compared with paclitaxel-eluting stents for treatment of drug-eluting and bare-metal stent restenoses – an observational registry |
|
S. Markovic, W. Rottbauer, J. Wöhrle (Ulm) |
| (P1730) |
Angiographic and Clinical Outcomes of Paclitaxel coated Balloon Angioplasty versus uncoated Balloon Angioplasty in Drug Eluting Stent Restenosis: Insights from the PEPCAD-DES study |
|
H. Rittger, J. Brachmann, M. Waliszewski, A.-M. Sinha, T.-V. Nguyen, S. Lonke, M. von Cranach, W. G. Daniel, J. Wöhrle (Erlangen, Coburg, Berlin, Hof, Ulm) |
| (P1731) |
Microembolization During Elective Coronary Stenting in Diabetic Patients Is Associated Not Only With Troponin Elevation but Also With Poor Long-Term Outcomes |
|
S. Otto, M. Seeber, M. Ferrari, B. Goebel, H.-R. Figulla, T. Poerner (Jena) |
| (P1732) |
Cost-Effectiveness of Drug-Eluting Balloon Angioplasty and Drug-Eluting Stent Implantation for Treatment of Coronary In-Stent Restenosis
|
|
M. Dorenkamp, A. Leber, C. Sohns, M. Roser, L.-H. Boldt, W. Haverkamp, K. Bonaventura (Berlin, München, Göttingen, Potsdam) |
| (P1733) |
One-year outcome after percutaneous treatment for de-novo coronary bifurcation lesion with bare metal stents (BMS), first and second generation drug eluting stents (DES). |
|
M. Ferenc, H. J. Büttner, H.-P. Bestehorn, M. Gick, T. Comberg, J. Rothe, C. M. Valina, N. Löffelhardt, A. Toma, F.-J. Neumann (Bad Krozingen) |
| (P1734) |
SeQuent Please Worl Wide Registry: Results of paclitaxel coated balloon angioplasty for treatment of de-novo coronary artery disease |
|
J. Wöhrle, W. Motz, S. Möbius-Winkler, M. Leschke, C. Opitz, B. Scheller (Ulm, Karlsburg, Leipzig, Esslingen, Berlin, Homburg/Saar) |
| (P1735) |
Drug Eluting Balloon Releasing Paclitaxel for Treatment of Coronary Restenosis in Bare Metal- and Drug Eluting Stents: Twelve-Month Follow-Up Results from the European PEPPER FIM Trial |
|
R. Tölg, G. Richardt, M. Wiemer, H. Schneider, M. Lesiak, C. K. Naber, E. Hoffmann, E. Jorgensen, J. Kubica, U. Dietz, C. Hehrlein (Bad Segeberg, Bad Oeynhausen, Rostock, Essen, München, Wiesbaden, Freiburg im Breisgau; Poznan, Bydgoszcz, PL; Kopenhagen, DK) |
| (P1736) |
Prognostic impact of using drug-eluting-stents on outcome and strategy in multivessel PCI: data from the Frankfurt MV-PCI registry |
|
T. Schwietz, S. Fichtlscherer, G. Baier, L. Held, C. Hobler, V. Schächinger, A. M. Zeiher, I. Spyridopoulos, R. Lehmann (Frankfurt am Main, Fulda; Newcastle Upon Tyne, UK) |
| (P1737) |
Five-Year Results of the SCORPIUS Study
A German Multicenter Investigation on the Effectiveness of Sirolimus Eluting Stents in Diabetic Patients |
|
J.-M. Sinning, D. Baumgart, N. Werner, V. Klauss, F. M. Baer, F. Hartmann, H. Drexler, W. Motz, H. Klues, W. Voelker, T. Pfannebecker, H.-P. Stoll, G. Nickenig (Bonn, Essen, München, Köln, Eutin, Hannover, Karlsburg, Krefeld, Würzburg, Norderstedt; Bridgewater, US) |